Conduit Pharmaceuticals Announces Advancements in Lupus Treatment Research
March 28, 2025
News
Lupus Foundation of America Announces LFA LIFT to Accelerate Development of New Lupus Treatments
March 27, 2025
News
New Study Identifies Potential Biomarkers for Predicting Effectiveness of Mesenchymal Stem Cell Transplantation Therapy in People with Systemic Lupus Erythematosus
March 24, 2025
News
Healthy Lifestyle Intervention Shows Promise for Individuals with Systemic Lupus Erythematosus
March 21, 2025
News
Highlights from the Systemic Lupus International Collaborating Clinics World Lupus Seminar on Africa
March 20, 2025
News
New Study Evaluates the Modified NIH Scoring System's Effectiveness in Predicting End-Stage Kidney Disease in Latin American People with Lupus Nephritis
March 11, 2025
News
New Study Highlights the Impact of Flares and Persistently Active Disease on Organ Damage in People with Systemic Lupus Erythematosus
March 6, 2025
News
FDA Accepts Supplemental Biologics License Application for Gayzva for Treatment of Lupus Nephritis
March 5, 2025
News
New Study Investigates the Role of microRNA-203 as a Potential Biomarker for Lupus Nephritis
February 28, 2025
News
Conduit Pharmaceuticals Partners with Charles River Laboratories to Evaluate AZD1656 for Lupus Treatment
February 24, 2025
News
New Study Finds Anifrolumab In Addition to Standard of Care Treatment is Effective at Reducing Organ Damage Accumulation
February 21, 2025
News
UPDATE: Investigational CAR-T Cell Therapy ADI-001 Receives FDA Fast Track Designation for Refractory Systemic Lupus Erythematosus with Extrarenal Involvement
February 7, 2025
News